I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 15 studies | 28% ± 10% | |
| macrophage | 10 studies | 29% ± 9% | |
| adipocyte | 10 studies | 30% ± 6% | |
| fibroblast | 10 studies | 27% ± 12% | |
| astrocyte | 10 studies | 36% ± 16% | |
| natural killer cell | 9 studies | 27% ± 12% | |
| CD16-positive, CD56-dim natural killer cell, human | 9 studies | 21% ± 9% | |
| microglial cell | 9 studies | 26% ± 7% | |
| mast cell | 9 studies | 29% ± 10% | |
| glutamatergic neuron | 8 studies | 40% ± 25% | |
| oligodendrocyte precursor cell | 8 studies | 28% ± 13% | |
| B cell | 6 studies | 29% ± 7% | |
| T cell | 6 studies | 33% ± 7% | |
| GABAergic neuron | 6 studies | 44% ± 21% | |
| epithelial cell | 5 studies | 36% ± 20% | |
| CD16-negative, CD56-bright natural killer cell, human | 5 studies | 26% ± 9% | |
| CD4-positive, alpha-beta T cell | 5 studies | 26% ± 10% | |
| CD8-positive, alpha-beta T cell | 5 studies | 25% ± 9% | |
| dendritic cell | 5 studies | 24% ± 4% | |
| ciliated cell | 5 studies | 22% ± 4% | |
| myeloid cell | 5 studies | 27% ± 6% | |
| monocyte | 5 studies | 37% ± 9% | |
| pericyte | 5 studies | 25% ± 7% | |
| smooth muscle cell | 5 studies | 23% ± 5% | |
| lymphocyte | 4 studies | 43% ± 19% | |
| endothelial cell of lymphatic vessel | 4 studies | 22% ± 1% | |
| type I pneumocyte | 4 studies | 20% ± 4% | |
| basal cell | 4 studies | 33% ± 21% | |
| interneuron | 4 studies | 45% ± 24% | |
| neuron | 3 studies | 24% ± 7% | |
| GABAergic interneuron | 3 studies | 21% ± 2% | |
| plasma cell | 3 studies | 23% ± 6% | |
| effector memory CD8-positive, alpha-beta T cell | 3 studies | 27% ± 8% | |
| endothelial cell of vascular tree | 3 studies | 26% ± 13% | |
| hepatocyte | 3 studies | 52% ± 25% | |
| ependymal cell | 3 studies | 32% ± 13% | |
| alveolar macrophage | 3 studies | 45% ± 13% | |
| type II pneumocyte | 3 studies | 18% ± 2% | |
| leukocyte | 3 studies | 40% ± 12% | |
| CD8-positive, alpha-beta memory T cell | 3 studies | 21% ± 3% | |
| regulatory T cell | 3 studies | 21% ± 5% |
